CAMBRIDGE, Mass., Sept. 22 /PRNewswire-FirstCall/ -- Infinity Pharmaceuticals, Inc. , an innovative cancer drug discovery and development company, today announced that Steven H. Holtzman, Chief Executive Officer, will be presenting a company overview at the UBS Global Life Sciences Conference. The presentation will take place on Tuesday, September 26, 2006 at 8:00 a.m. EDT (5:00 a.m. PDT) at the Grand Hyatt Hotel in New York, NY.
A webcast of Infinity’s presentation will be accessible on the company’s website at http://www.ipi.com beginning at 11:00 a.m. EDT on Tuesday, September 26, 2006. The webcast will be archived on the company’s website for 30 days.
About Infinity Pharmaceuticals, Inc.
Infinity is an innovative cancer drug discovery and development company that is seeking to leverage its strength in small molecule drug technologies to discover, develop, and deliver to patients first-in-class or best-in-class medicines for the treatment of cancer and related conditions. For more information on Infinity, please refer to the company’s website at http://www.ipi.com.
Contacts: Investors: John Evans 617.453.1254 John.Evans@ipi.com Media: Monique Allaire 617.453.1105 Monique.Allaire@ipi.com
Infinity Pharmaceuticals, Inc.
CONTACT: John Evans, Investor contact, +1-617-453-1254,John.Evans@ipi.com, or Monique Allaire, Media contact, +1-617-453-1105,Monique.Allaire@ipi.com, both of Infinity Pharmaceuticals, Inc.
Web site: http://www.ipi.com/
